Starting Jan. 1, 2026, Medicare will slash prices on 10 common drugs for heart disease, diabetes, and more. See if your ...

Trump and Biden administration policies seeking to rein in high prescription drug prices are slated to go into effect in the new year, setting up various overlapping plans with which drug companies ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

Discover the major changes to Medicare Part D for 2026, including lower prices for 10 key drugs, a new out-of-pocket cap of ...

For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs.

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.

They agreed to charge the U.S. government no more for new drugs than the prices paid by other well-off countries. The agreements will allow state Medicaid programs to access lower prices from the nine ...

The deal announced Friday tacks on to similar reduced price agreements the Trump administration has made with five other ...

Dallas, this week highlighted progress under the Trump Administration to lower prescription drug prices, following recent commitments from pharmaceutical manufacturers to adopt Most Favored Nation ...

Analysts see little effect on the bottom lines of biopharma companies, as they stand to stave off tariff pressure and receive ...